Reuters logo
BRIEF-Aviragen Therapeutics Q3 loss per share $0.11
May 4, 2017 / 11:14 AM / 6 months ago

BRIEF-Aviragen Therapeutics Q3 loss per share $0.11

May 4 (Reuters) - Aviragen Therapeutics Inc

* Aviragen therapeutics reports third quarter fiscal year 2017 financial results

* Q3 loss per share $0.11

* Q3 revenue $4.9 million versus $5.3 million

* Q3 revenue view $3 million -- Thomson Reuters I/B/E/S

* Q3 earnings per share view $-0.21 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below